The Study
Testosterone Replacement, Where Are We in 2025?
This article is like a teacher summarizing what other scientists have found about testosterone therapy — but it didn’t do any experiments itself. So it can tell you what others think, but it can’t prove anything new.
Analysis score
Maximum 5 for a narrative review.
Where the score came from
Doctors used to say no to testosterone for men with heart issues or cancer, but now they look at each person’s risks and benefits. New ways to take it (like pills or shots under the skin) are easier, and tests can now tell who might benefit most.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 51 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — men who were previously denied treatment can now be considered on a case-by-case basis, expanding access safely.
- 2FDA removed black box warnings in 2025 after the TRAVERSE trial; new delivery methods (subcutaneous, oral) improve adherence; diagnostics now use biomarkers and genetic testing; monitoring is tailored to risk.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Trends in Urology & Men's Health
Year
2025
Authors
Arnaav Walia, Peyton Coady, Beatriz Sofia‐Hernandez, Haarika Gudlavalleti, A. El-Achkar, Shannon Elise Dunnam, V. Madhusoodanan, Taylor P. Kohn, Mohit Khera
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.